Loading...
Loading...
Loading...
Loading...
Try browsing our complete catalog of products.
No reviews have been added for this product.
Atlas Antibodies
Atlas Antibodies
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | TAYAIIKEELDEDFEQLCEEIQESRKKRGCSSSKYAPSYYHVMPKQNSTLVGDKRSDPEQNEKLKTPSTPVACSTPAQLKRKIRKKSNWYLGTIKKRRKISQAKDDSQNAIDHK |
| Gene Sequence | TAYAIIKEELDEDFEQLCEEIQESRKKRGCSSSKYAPSYYHVMPKQNSTLVGDKRSDPEQNEKLKTPSTPVACSTPAQLKRKIRKKSNWYLGTIKKRRKISQAKDDSQNAIDHK |
| Gene ID - Mouse | ENSMUSG00000022360 |
| Gene ID - Rat | ENSRNOG00000025604 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) | |
| Datasheet | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) | |
| Datasheet | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) |
| Citations for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) – 4 Found |
| Raeder, Maria B; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I; Krohn, Antje; Werner, Henrica Mj; Moody, Susan E; Wik, Elisabeth; Stefansson, Ingunn M; Holst, Frederik; Oyan, Anne M; Tamayo, Pablo; Mesirov, Jill P; Kalland, Karl H; Akslen, Lars A; Simon, Ronald; Beroukhim, Rameen; Salvesen, Helga B. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. Plos One. 8(2):e54873. PubMed |
| Wan, Wei-Na; Zhang, Yi-Xia; Wang, Xue-Mei; Liu, Yan-Jun; Zhang, Yu-Qin; Que, Yan-Hong; Zhao, Wen-Jing. ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis. Asian Pacific Journal Of Cancer Prevention : Apjcp. 15(6):2777-83. PubMed |
| Liu, Qun; Liu, Heshu; Li, Lina; Dong, Xiaomei; Ru, Xiaoli; Fan, Xiana; Wen, Tao; Liu, Jian. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation. International Journal Of Oncology. 2020;56(1):219-231. PubMed |
| Hwang, Yo Sep; Park, Eun Sun; Oh, Byung Moo; Uhm, Tae Gi; Yoon, Suk Ran; Park, Jong-Lyul; Cho, Hee Jun; Lee, Hee Gu. miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2. Cancers. 2022;14(18) PubMed |
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | TAYAIIKEELDEDFEQLCEEIQESRKKRGCSSSKYAPSYYHVMPKQNSTLVGDKRSDPEQNEKLKTPSTPVACSTPAQLKRKIRKKSNWYLGTIKKRRKISQAKDDSQNAIDHK |
| Gene Sequence | TAYAIIKEELDEDFEQLCEEIQESRKKRGCSSSKYAPSYYHVMPKQNSTLVGDKRSDPEQNEKLKTPSTPVACSTPAQLKRKIRKKSNWYLGTIKKRRKISQAKDDSQNAIDHK |
| Gene ID - Mouse | ENSMUSG00000022360 |
| Gene ID - Rat | ENSRNOG00000025604 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) | |
| Datasheet | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) | |
| Datasheet | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) |
| Citations for Anti ATAD2 pAb (ATL-HPA029424 w/enhanced validation) – 4 Found |
| Raeder, Maria B; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I; Krohn, Antje; Werner, Henrica Mj; Moody, Susan E; Wik, Elisabeth; Stefansson, Ingunn M; Holst, Frederik; Oyan, Anne M; Tamayo, Pablo; Mesirov, Jill P; Kalland, Karl H; Akslen, Lars A; Simon, Ronald; Beroukhim, Rameen; Salvesen, Helga B. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. Plos One. 8(2):e54873. PubMed |
| Wan, Wei-Na; Zhang, Yi-Xia; Wang, Xue-Mei; Liu, Yan-Jun; Zhang, Yu-Qin; Que, Yan-Hong; Zhao, Wen-Jing. ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis. Asian Pacific Journal Of Cancer Prevention : Apjcp. 15(6):2777-83. PubMed |
| Liu, Qun; Liu, Heshu; Li, Lina; Dong, Xiaomei; Ru, Xiaoli; Fan, Xiana; Wen, Tao; Liu, Jian. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation. International Journal Of Oncology. 2020;56(1):219-231. PubMed |
| Hwang, Yo Sep; Park, Eun Sun; Oh, Byung Moo; Uhm, Tae Gi; Yoon, Suk Ran; Park, Jong-Lyul; Cho, Hee Jun; Lee, Hee Gu. miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2. Cancers. 2022;14(18) PubMed |